Patient recruitment servicesThe patient retention and recruitment services market has been predicted to attain their market value in the year 2030, based on the recent report. The report came from the industry research and consulting company that examined approximately about 140 companies tendering patient retention and recruitment services. From the report, their market has been fragmented with the mix of small, medium, and large-sized companies. Delays in the clinical trial recruitment had been one of the main important cost factors in the drug development. The sponsors are increasingly putting their outside the United States in the areas like the Asia and the Eastern Europe. The consulting firms are making this to have access to the populations of the patients that are therapy naïve and are motivated to take part in these trials. This progress towards the new markets isn’t because of the shortage of patients in the USA, but the failure to efficiently build awareness, educate and engage the patients to successfully enroll in the trials. Report by the figures:
Based on the report, most of the service providers are situated in Europe and in North America, though the growing numbers are rising in the Asia-Pacific and some other developing regions. In the research, it has been found that there are more than 60% of the companies claimed to use the social media platforms in enrolling patients in the clinical studies. The traditional broadcasting platforms such as TV, radio, and newspapers makes up the next most famous medium for the patient outreach campaigns which are also being used at around 41 percent of stakeholders. The cited outreach systems include the Print advertisement with 32%, the patient advocacy groups with 32%, the physician referrals with 30%, the cold call or call centers with 28%, the patient networks with 27%, the proprietary patient databases with 27%, the direct mail or e-mail with 24%, in adding up to the electronic medical records or EMRs, the health care data and pharmacy with 14%.
The advances in technology had given tools that will aid in identifying eligible patients with the physician’s database which are likely to succeed for the study. But physicians and some of the staffs often lack the time, tools, and skills in educating the present patient about the clinical trials and then motivate them to assent.” With the fast growth of these clinical trial industries, greater efficiency and effectiveness and will be needed. In the clinical trials to really become more effective we as a business will need to become more positive in educating and informing the general public regarding the clinical trials.”
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
February 2020
Categories |